Please Wait

Applying Filters...

Stieprox
KDMF
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Stieprox

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 6 USDMF, 5 CEP/COS, 1 KDMF, 5 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers, 32 FDA Orange Book, 53 Europe, 3 Canada, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%, SUSPENSION;TOPICAL - 0.77%, GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens, 1 DKSH, 5 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 Actylis, 8 BASF, 2 Corel Pharma Chem, 1 Finar, 2 Lubrizol Life Science Health, 1 Pluviaendo, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical, 7 Parenteral, 5 Solubilizers, 3 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 3 Granulation, 2 Coating Systems & Additives, 2 Emulsifying Agents, 2 Lubricants & Glidants, 2 Taste Masking, 1 Surfactant & Foaming Agents, 1 Controlled & Modified Release, 1 Direct Compression

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 38 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

REF. STANDARDS & IMPURITIES

4 EDQM, 10 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Shanghai Pharma Group	China	Ace Biopharm Co., Ltd.	20190111-209-J-300	Ciclopirox	2019-01-11	Shanghai Pharma Group Changzhou Kony Pharmaceutical Co.,Ltd.	China	No. 35-1, Yixi Road, Daixi, Luoyang Town, Wujin District, Changzhou, Jiangsu 213105, China

Contact us
to update this info

Stieprox

Stieprox

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers

6 USDMF

5 CEP/COS

1 KDMF

5 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers

32 FDA Orange Book

53 Europe

3 Canada

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%

SUSPENSION;TOPICAL - 0.77%

GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens

1 DKSH

5 Nanjing Well Pharmaceutical

1 Kirsch Pharma

2 Actylis

8 BASF

2 Corel Pharma Chem

1 Finar

2 Lubrizol Life Science Health

1 Pluviaendo

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Topical

7 Parenteral

5 Solubilizers

3 Thickeners and Stabilizers

3 Film Formers & Plasticizers

3 Granulation

2 Coating Systems & Additives

2 Emulsifying Agents

2 Lubricants & Glidants

2 Taste Masking

1 Surfactant & Foaming Agents

1 Controlled & Modified Release

1 Direct Compression

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

38 Regulatory FDF Prices

MARKET PLACE

9 APIs

REF. STANDARDS & IMPURITIES

4 EDQM

10 Others

Filters

GEL;TOPICAL - 0.77% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons